NSAIDs and cardiovascular disease.
作者信息
Patrignani Paola, Capone Marta L, Tacconelli Stefania
出版信息
Heart. 2008 Apr;94(4):395-7. doi: 10.1136/hrt.2007.136002.
PMID:18347364
Abstract
摘要
相似文献
1
NSAIDs and cardiovascular disease.非甾体抗炎药与心血管疾病
Heart. 2008 Apr;94(4):395-7. doi: 10.1136/hrt.2007.136002.
2
Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.关于使用非甾体抗炎药（包括环氧化酶-2酶抑制剂和阿司匹林）的共识发展会议。
Clin Gastroenterol Hepatol. 2006 Sep;4(9):1082-9. doi: 10.1016/j.cgh.2006.04.010. Epub 2006 Jul 31.
3
Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.环氧化酶-2抑制剂和传统非甾体抗炎药的心血管风险。
Ann Med. 2007;39(1):18-27. doi: 10.1080/07853890601073445.
4
[Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs].[选择性COX-2抑制剂和传统非甾体抗炎药的心血管毒性]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2007 Jul;42(7):514-7. doi: 10.1055/s-2007-985503.
5
[Drug safety of NSAIDs and COX-2 inhibitors].[非甾体抗炎药和COX-2抑制剂的药物安全性]
Med Monatsschr Pharm. 2006 Apr;29(4):122-8.
6
[Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].[环氧化酶-2抑制剂和非甾体抗炎药在伤害性疼痛患者中的作用的进一步定义]
Ned Tijdschr Geneeskd. 2007 Jun 9;151(23):1313; author reply 1313-4.
7
Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.环氧化酶-2抑制剂、非甾体抗炎药与心血管风险
Intern Med J. 2006 Dec;36(12):797-8; author reply 798-9. doi: 10.1111/j.1445-5994.2006.01187.x.
8
Cardiovascular adverse reactions from NSAIDs are more than COX-2 inhibition alone.
Rheumatology (Oxford). 2010 May;49(5):834-6. doi: 10.1093/rheumatology/kep451. Epub 2010 Jan 22.
9
Cardiovascular effects of low-dose aspirin, traditional non-steroidal anti-inflammatory drugs and coxibs.
Bull Mem Acad R Med Belg. 2010;165(1-2):115-23; discussion 124.
10
Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.药物洞察：环氧化酶-2抑制剂——批判性评估
Nat Clin Pract Rheumatol. 2007 Oct;3(10):552-60; quiz 1 p following 589. doi: 10.1038/ncprheum0619.
引用本文的文献
1
Why Pharmacovigilance of Non-steroidal Anti-inflammatory Drugs is Important in India?为什么印度的非甾体抗炎药药物警戒很重要？
Endocr Metab Immune Disord Drug Targets. 2024;24(7):731-748. doi: 10.2174/0118715303247469230926092404.
2
Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk.血小板与癌细胞相互作用对环氧合酶-2表达调控的新见解。
Biochem Soc Trans. 2015 Aug;43(4):707-14. doi: 10.1042/BST20140322. Epub 2015 Aug 3.
3
Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer.表观遗传学克服促炎的前列腺素内过氧化物合酶转录组特征，导致结直肠癌中前列腺素E2的选择性过度激活。
Clin Epigenetics. 2015 Jul 24;7(1):74. doi: 10.1186/s13148-015-0110-4. eCollection 2015.
4
Clinical disease registries in acute myocardial infarction.急性心肌梗死的临床疾病登记
World J Cardiol. 2014 Jun 26;6(6):415-23. doi: 10.4330/wjc.v6.i6.415.
5
Grand challenges in pharmacotherapy of inflammation for the first decades of the 21st century.21世纪前几十年炎症药物治疗面临的重大挑战。
Front Pharmacol. 2010 May 6;1:2. doi: 10.3389/fphar.2010.00002. eCollection 2010.
6
Risk management profile of etoricoxib: an example of personalized medicine.依托考昔的风险管理概况：个体化医学的一个范例。
Ther Clin Risk Manag. 2008 Oct;4(5):983-97. doi: 10.2147/tcrm.s3209.
Zotero 插件